|
|
|
|
Relative Bioavailability and Pharmacokinetics of Darunavir when boosted with the Pharmacoenhancer GS-9350 versus Ritonavir
|
|
|
Reported by Jules Levin
International Workshop on Clinical Pharmacology of HIV Therapy
April 7-9, 2010
Sorrento, Italy
Anita Mathias1, Hui C. Liu1, David Warren1, Vanitha Sekar2, and Brian P. Kearney11 Gilead Sciences, Inc., Foster City, CA 944042 Tibotec, Inc., Yardley, PA 19027
|
|
|
|
|
|
|